Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment.
Federal court backs FDA’s approval of competitor to Jazz’s sleep drug
The US District Court for Washington, DC, on Wednesday ruled against Jazz Pharmaceuticals’ attempt to undo the FDA’s approval of a competing sleep drug from
November 1, 2024